2024-09-03 - Analysis Report
## MRK Stock Analysis

**Company Overview:** Merck & Co., Inc. is a leading global pharmaceutical company known for its innovative medicines and vaccines.

**1. Performance vs. S&P 500 (VOO):**

MRK's cumulative return over the period is **52.93%**, lagging behind the S&P 500's (VOO) return of **89.66%**. This results in a **-36.73%** difference, which represents **38.25%** of the historical range between the minimum and maximum difference. 

**2. Recent Price Movement:**

* **Closing Price:** $118.45
* **5-Day Moving Average:** $117.22
* **20-Day Moving Average:** $114.88
* **60-Day Moving Average:** $122.73

The stock is currently trading above its 5-day and 20-day moving averages, suggesting short-term upward momentum. However, the 60-day moving average is higher, indicating potential for a pullback.

**3. Technical Indicators:**

* **RSI:** 81.9 - This suggests the stock is currently in overbought territory, implying a potential correction in the near future.
* **PPO:** 0.74 -  A positive PPO value indicates that the price is above its moving average, which is consistent with the current price action.
* **Delta_Previous_Relative_Divergence:** -6.71 - The recent relative divergence is negative, indicating a potential short-term decline.
* **Expected_Return:** 11.87% -  This represents the potential maximum expected return over the next 5 years for current investments.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue | 
|---|---|---|
| 2024-08-05 | 2.15 | $16.11 B |
| 2024-05-03 | 1.88 | $15.78 B |
| 2023-11-03 | 1.87 | $15.96 B |
| 2023-08-07 | -2.35 | $15.04 B |
| 2024-08-05 | -2.35 | $15.04 B | 

The most recent earnings report, released on August 5th, 2024, showed an EPS of $2.15, exceeding analysts' expectations. Revenue also came in slightly higher than anticipated. The company's earnings growth has been consistent in recent quarters, demonstrating a positive trend.

**5. Overall Analysis:**

MRK has exhibited a strong performance in recent quarters, with consistent earnings growth and exceeding analyst expectations. However, the stock is currently trading in overbought territory, and the recent negative relative divergence indicates potential for a short-term decline. While the expected return is positive, investors should be cautious about potential short-term volatility. 

**6. Conclusion:**

While MRK's fundamentals remain strong, the current technical indicators suggest caution for short-term investment. Long-term investors with a longer time horizon may find the current price attractive considering the company's consistent earnings growth and positive future prospects. However, short-term traders should monitor the price action closely for potential corrections. 
